ADMA-49.81%20.0%
DYN+175.80%20.0%
INSM+22.35%20.0%
IONS+51.68%20.0%
NBIX+33.82%20.0%
As of Jul 10, 2026, 7:14 AM ET
Rare Diseases '25: RNA Therapy & Protein Mod Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Insmed IncorporatedINSM | 20.0% | 0.74% | 1.48% | 12.91% | 10.52% | -32.05% | -20.81% | 61.03% | 22.35% | $25.63B |
Neurocrine Biosciences, Inc.NBIX | 20.0% | 0.00% | 1.30% | 6.21% | 7.62% | 27.30% | 36.52% | 66.70% | 33.82% | $18.15B |
Ionis Pharmaceuticals, Inc.IONS | 20.0% | 0.19% | -23.89% | -20.34% | -18.83% | -18.75% | -20.79% | 123.89% | 51.68% | $10.62B |
Dyne Therapeutics, Inc.DYN | 20.0% | -0.10% | 1.85% | 14.16% | 11.38% | 24.08% | 55.38% | 144.90% | 175.80% | $4.01B |
ADMA Biologics, Inc.ADMA | 20.0% | 0.43% | 1.20% | 10.75% | 7.67% | -49.18% | -40.46% | -54.18% | -49.81% | $2.15B |
| Theme return | — | 0.25% | -3.61% | 4.74% | 3.92% | -10.49% | -0.18% | 67.72% | 41.59% | — |
| Average | 20.0% | 0.25% | -3.61% | 4.74% | 3.67% | -9.72% | 1.97% | 68.47% | 46.77% | $12.11B |
| Median | 20.0% | 0.19% | 1.30% | 10.75% | 7.67% | -18.75% | -20.79% | 66.70% | 33.82% | $10.62B |
| Std Dev | 0.0% | 0.30% | 10.14% | 12.83% | 11.35% | 30.50% | 37.10% | 69.30% | 73.16% | $8.79B |
| Min | 20.0% | -0.10% | -23.89% | -20.34% | -18.83% | -49.18% | -40.46% | -54.18% | -49.81% | $2.15B |
| Max | 20.0% | 0.74% | 1.85% | 14.16% | 11.38% | 27.30% | 55.38% | 144.90% | 175.80% | $25.63B |
| % Positive Tickers | 60.00% | 80.00% | 80.00% | 80.00% | 40.00% | 40.00% | 80.00% | 80.00% |
About this theme
Rare Diseases '25: RNA Therapy & Protein Mod tracks 5 publicly listed stocks in this theme: ADMA, DYN, INSM, IONS, NBIX. See the constituent table for details.